Evaluation of 1-Year vs Shorter Durations of Adjuvant Trastuzumab Among Patients With Early Breast Cancer: An Individual Participant Data and Trial-Level Meta-analysis

IMPORTANCE: The optimum duration of adjuvant trastuzumab among patients with early breast cancer is uncertain but of great therapeutic relevance. OBJECTIVE: To compare shorter durations with 1 year of adjuvant trastuzumab for patients with early breast cancer. DATA SOURCES: PubMed, Embase, Cochrane...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Netw Open
Main Authors: Gulia, Seema, Kannan, Sadhana, Badwe, Rajendra, Gupta, Sudeep
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2020
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445596/
https://ncbi.nlm.nih.gov/pubmed/32833018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.11777
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker